abbvie glp-1 receptor agonist Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH abbvie glp-1 Enters Obesity Field,

Notices required by state law were mailed to owners and published in the Austin American Statemen by July 8, 2026

Somatostatin normally puts the brakes on growth hormone release

Kimberly Anne Gudzune of @HopkinsMedicine, recorded @SocietyGIM #SGIM23 in Denver, Colorado Show Segments Intro Barriers to treating medicine in primary care Patient counseling and obesity pathophysiology Motivational Interviewing Telemedicine for obesity Tools and tips for a weight loss program Medications for Obesity GLP1 agonist prescribing tips Outro Obesity Medicine Pearls Obesity is a chronic disease

2017 May;119:128-136

Disagreements were resolved through consensus or a third reviewer (AFW)